⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22115653 | 0.69 | ALDH1A1 (0.35) | — | |
| SCHEMBL3248772 | 0.67 | — | — | |
| SCHEMBL4474893 | 0.64 | — | — | |
| SCHEMBL5274450 | 0.64 | ALDH1A1 (0.38) | — | |
| SCHEMBL8570871 | 0.64 | — | — | |
| SCHEMBL1778620 | 0.64 | — | — | |
| SCHEMBL2040354 | 0.62 | — | — | |
| SCHEMBL7227524 | 0.62 | — | — | |
| SCHEMBL7928068 | 0.62 | — | — | |
| SCHEMBL22401338 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111320535-B | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-111320535-A | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2020-06-23 | — | — | CN | claimed |
| CN-104262121-A | Method for synthesizing 1,3-dibromo-2,2-dimethoxy propane | SUZHOU VIVOTIDE BIOTECHNOLOGIES CO LTD | 2015-01-07 | — | — | CN | claimed |
| EP-4323358-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER | Hotspot Therapeutics, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| EP-4288429-A1 | LACTAMS AS CBL-B INHIBITORS | Genentech, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023081853-A1 | LACTAMS AS CBL-B INHIBITORS SELECTIVE OVER C-CBL | GENENTECH, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-RE49481-E1 | Compounds for the treatment and prophylaxis of respiratory syncytial virus disease | HOFFMANN-LA ROCHE INC. (US) | 2023-04-04 | — | — | US | disclosed |
| WO-2022221704-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER | HOTSPOT THERAPEUTICS, INC. (US) | 2022-10-20 | — | — | WO | disclosed |
| CN-111320535-B | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-111320535-B | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-111320535-A | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2020-06-23 | — | — | CN | disclosed |
| CN-104262121-A | Method for synthesizing 1,3-dibromo-2,2-dimethoxy propane | SUZHOU VIVOTIDE BIOTECHNOLOGIES CO LTD | 2015-01-07 | — | — | CN | disclosed |
| US-8871756-B2 | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease | HOFFMANN-LA ROCHE INC. (US) | 2014-10-28 | — | — | US | disclosed |
| EP-2742039-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F. Hoffmann-La Roche AG (CH) | 2014-06-18 | — | — | EP | disclosed |
| US-20130196974-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | HOFFMANN-LA ROCHE INC. | 2013-08-01 | — | — | US | disclosed |
| WO-2013020993-A1 | COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-02-14 | — | — | WO | disclosed |
| EP-2271625-A2 | TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | Abbott GmbH & Co. KG (DE) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009121872-A2 | TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY | ABBOTT GMBH & CO. KG (DE) | 2009-10-08 | — | — | WO | disclosed |
| EP-1807078-A1 | DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006042150-A1 | DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2006-04-20 | — | — | WO | disclosed |